Nephrology

1-9 of 9

• 

  RestartResume

  Rethinking Cardiovascular Risk: Uncovering the Blind Spots

  Conversations in CV Risk Assessment

  Rethinking Cardiovascular Risk: Uncovering the Blind Spots

  • 

    

    Jennifer Caudle, DO, FACOFP

    Peer

  • 

    

    Javed Butler, MD, MPH, MBA

    Peer

• 

  RestartResume

  Elevating CV Risk Assessment: Why uACR Deserves a Seat at the Table

  Conversations in CV Risk Assessment

  Elevating CV Risk Assessment: Why uACR Deserves a Seat at the Table

  • 

    

    Brian P. McDonough, MD, FAAFP

    Peer

  • 

    

    Javier Morales, MD, FACP, FACE

    Peer

• 

  RestartResume

  Primary Care and Cardiology: Shared Responsibility in Albuminuria Detection

  Conversations in CV Risk Assessment

  Primary Care and Cardiology: Shared Responsibility in Albuminuria Detection

  • 

    

    Jennifer Caudle, DO, FACOFP

    Peer

  • 

    

    Javed Butler, MD, MPH, MBA

    Peer

  • 

    

    Martha Gulati, MD, MS, FACC

    Peer

• 

  RestartResume

  Challenging Cases in IgA Nephropathy and Identifying Patients for Specialized Care

  Medical Industry Feature

  Challenging Cases in IgA Nephropathy and Identifying Patients for Specialized Care

  • 

    

    Jaimini Patel, PharmD, BCCCP

    Peer

  • 

    

    Sayna Norouzi, MD

    Peer

• 

  RestartResume

  The Role of APRIL and the 4-Hit Process in the Pathogenesis of IgA Nephropathy

  Medical Industry Feature

  The Role of APRIL and the 4-Hit Process in the Pathogenesis of IgA Nephropathy

  • 

    

    Edgar V. Lerma, MD, FACP, FASN, FPSN (Hon)

    Peer

  • 

    

    Luis E. Vélez, MD

    Peer

• 

  RestartResume

  Navigating IgA Nephropathy: Pathogenesis, The Role Of APRIL & The 4-Hit Process, & A Patient Case Study

  Medical Industry Feature

  Navigating IgA Nephropathy: Pathogenesis, The Role Of APRIL & The 4-Hit Process, & A Patient Case Study

  • 

    

    Abigail Yancey, PharmD, BCPS

    Peer

  • 

    

    Kartik Kalra, MD

    Peer
• advertisement

• 

  RestartResume

  Expert Opinions on Characteristics of Patients With C3G at High Risk of Progression

  Medical Industry Feature

  Expert Opinions on Characteristics of Patients With C3G at High Risk of Progression

  • 

    

    Dana Rizk, MD

    Peer

  • 

    

    Carla Nester, MD

    Peer

  • 

    

    Sanjeev Sethi, MD, PhD

    Peer

  • 

    

    Leal Herlitz, MD

    Peer

• 

  RestartResume

  Expert Opinions on Characteristics of Patients With IgA Nephropathy (IgAN) at High Risk of Progression

  Medical Industry Feature

  Expert Opinions on Characteristics of Patients With IgA Nephropathy (IgAN) at High Risk of Progression

  • 

    

    Dana Rizk, MD

    Peer

  • 

    

    Carla Nester, MD

    Peer

  • 

    

    Sanjeev Sethi, MD, PhD

    Peer

  • 

    

    Leal Herlitz, MD

    Peer

• 

  RestartResume

  Expert Opinions on Renal Compensation and Renal Functional Reserve

  Medical Industry Feature

  Expert Opinions on Renal Compensation and Renal Functional Reserve

  • 

    

    Jai Radhakrishnan, MD

    Peer

  • 

    

    Leal Herlitz, MD

    Peer